Lindsay Rosenwald

RSS | Comments RSS

Lindsay Rosenwald & Charitable Online Mentions

June 16, 2010 at 2:59 pm

Lindsay Rosenwald Online Mentions

Dr. Lindsay Rosenwald is a member of Board of Directors at the Republican Jewish Coalition. His short biography can be found on their official website www.rjchq.org . Being one of the most broadly-informed and connected people in the biotechnology financing sector, Dr. Rosenwald at the head of his Paramount Capital company contributes greatly to private equity, venture capital, and hedge funds.

On the MucketyMaps site, Lindsay Rosenwald’s relationship to Paramount Capital Asset Management Inc. and Republican Jewish Coalition is displayed in the form of map relationships.

Dr. Lindsay Rosenwald is a notable person in the Wellness.com community. Being a general practitioner in New York, NY, and a graduate from the Temple University Medical School, Lindsay Rosenwald offers such medical care services as general physical examinations, fitness programs, cholesterol testing, bone density testing, skin biopsies, immunization, stress reduction plans, skin biopsies, menopause treatment, ongoing evaluations and more.

Lindsay Rosenwald is an honorable member of the NyICECATS, all Jewish Orthodox Youth Hockey Organization. At the 3rd and 4th annual Captain’s Dinner that took place in Le Marais, NYC, on March 12th, Neil Herskowitz, Director at Manhattan Pharmaceuticals, Inc., presented Lindsay Rosenwald with the gifts of team, including a new Bauers 190. In the middle of the dinner, Dr. Lindsay Rosenwald announced that he committed to another 25 years of icetime at the Piers. The dinner was finished with the grand “Golden Balls” awards ceremony.

At the Huffington Post’s FundRace 2008, the search for Lindsay Rosenwald returns his contribution to McCain Victory Committee that received the donation of $61,800 from Dr. Lindsay Rosenwald.

Paramount Biosciences Company

June 12, 2010 at 2:53 pm

Paramount BioSciences, LLC (“Paramount”) is a major pharmaceutical drug development and investment organization having their principal concentration on the medical and life sciences industries. By using Paramount BioCapital, Inc., a FINRA listed broker-dealer in charge of funding and raising capital for Portfolio businesses, Paramount BioSciences greatly plays a role in the emergence and progression of modern biotechnologies and life sciences.

Paramount Biosciences’’ Brand

Not only will Paramount BioSciences furnish specialized solutions and assistance, but is additionally involved in new product enhancement, Biotech Corporation’s acquisition and development. It facilitates the freshly generated organizations in several value-adding ways. They evaluate product prospects for the Portfolio businesses; generate development strategies to facilitate the creation procedure ahead of, in the course of, as well as after the formation of Portfolio Firms. Both, back up and experience is entirely supported by BioSciences as it enables its Portfolio Firms to gain access to far more knowledgeable infrastructure than some might have. This allows the company operations to pay attention to the drug candidates’ growth instead of developing their unique infrastructure. In many ways, this kind of model produced by Paramount’s founder Lindsay Rosenwald offers both expert and “back office” help and limits delays inside the development process, in addition to maximized the profits for Portfolio firms and the patient group.

After approval and in-licensing, a role-specific administration team throughout the full creation period maintains pharmaceutical candidates. Senior pharmaceutical progression personnel at Paramount BioSciences, which include Lindsay Rosenwald, help Portfolio Firms in all of the aspects of pharmaceutical creation. This includes formulation, clinical growth, toxicology, developing, monitoring quality, and marketing. With their substantial practical experience in establishing top drug solutions, the Paramount’s group delivers options for a variety of therapeutically signs, beginning with inflammation to cardiovascular to oncology to neurology and lots of other indications. Global system of professionals as well as business market leaders in the health-related and technological fields provides assistance through the candidates’ development and acceptance period.

Having a proven track record, Paramount BioSciences facilitates Portfolio Firms hire executives that will steer the fresh businesses made throughout the new compounds. Among the current hires at Portfolio Firms, there are such executives as the former CEOs of Roche, Biogen, Johnson&Johnson, Amgen and many more.

Over two decades of financing and development of biomedical companies around a broad range of therapeutic indications, Lindsay Rosenwald is head of Paramount BioSciences’ more than 40 biotech corporations. He forms companies from the scratch employing his very own capital after which funds are raised from different private individuals through Paramount Capital.

Paramount deals with critical capabilities as accounting, legal, market analytical, monetary capabilities. This allows its Portfolio firms to give attention to scientific experiments and generating value for shareholders, licensors and patients.

With this kind of experience for locating and creating modern medications, Paramount BioSciences evaluates the quality and promises of drug candidates across the world, from little biotech companies and educational centers to large prescription firms.

Paramount Procedure To Value Creation

Exactly what tends to make Paramount BioSciences stand out, is the fact that their infrastructure and outer network permits them to assistance Paramount Incubated Organizations until finally they come to be self-sufficient. The creation routine has been designed by Lindsay Rosenwald in 1998 and may be explained in a straightforward layout similar to this one:

Product Resources –> Paramount Original Financing and Expansion –> Incubation –> Portfolio Company Formation –> Cost Inflection Level

Employees for each Portfolio Company are chosen in compliance with developmental and monetary situations. Normally, most employees at Paramount have a minimum of 12-15 years of practical experience in biotechnology or health care industries maneuvering pharmaceutical applicants throughout the regulatory and clinical value string. Their expertise ranges from molecular biology to clinical medical science.

With this kind of serious knowledge throughout the pharmaceutical creation business, Lindsay Rosenwald has managed to form the group with leadership roles in the biotech market with numerous pharmaceutical products for sale globally, including Viracept, Neulasta, Rituxan, and Kepivance.

Paramount Business Units

Paramount Biosciences

With over forty staff in eight offices globally, Paramount BioSciences contend and bargain for college and business biotechnology entitlements. It develops and in-licenses compounds for numerous restorative indications – from inflammation and cardiology to neurology and cancer. Lindsay Rosenwald may help create standalone biotech firms that will get capital and triumph as public organizations

Paramount BioCapital, Inc.

Paramount BioCapital Inc. is a NASD-registered dealer that collects cash for the Portfolio Businesses. It brought in above $1 billion and around $200 million in 2009. Making use of their extensive know-how in investments purchases such as “PIPE’s”, reverse mergers, self-registrations and private positions, Paramount BioCapital is becoming the leader within the biotechnology capital market.

Paramount Corporate and business Advancement

Lindsay Rosenwald functions directly with Paramount Corporate Development, which is involved with in-licensing and pharmaceutical development functions. The Corporate Development team comprises of 20 trade veterans with a huge experience in most facets of pharmaceutical drug development, including formulation, clinical procedures, manufacturing and commercialization.

Paramount BioCapital Property Management

Property Management is in charge of buying and disbursing equities of worldwide healthcare organizations. They have a successful hedge fund structure and property under management in numerous private placement vehicles.

Paramount Acquisition Company

Paramount Acquisition Company produces distinctive private equity finance vehicles that match up substantial capitals with late-stage private companies. It just lately announced a $54 million purchase with Valeritas, which is a medical device business with its primary FDA-approved insulin pump h-Patch.

Paramount BioSciences Professional Leadership Staff

Typically, Paramount BioSciences personnel have 15 years of primary knowledge in the specialized medical and regulatory processes. Headed by Lindsay Rosenwald, the team members participated in lots of prescription creation and commercialization jobs, including Rituxan, Viracept, Sutent, Kepivance, and Neulasta. More than fifty substances currently go through clinical advancement procedure and the products consist of drug treatments throughout a broad range of indications that include neurological ailments, metabolic conditions, transmittable conditions and cancer.

Lindsay A. Rosenwald, M.D., is CEO and Chairman at Paramount BioSciences. His considerable expertise within biotechnology, pharmacology and finance made him one of the frontrunners in the biotechnology and life sciences sectors. With more than 19 years of practical experience in building and investing in biotechnology and life science organizations, Dr. Lindsay Rosenwald set up and nurtured more than 40 biotech/pharma organizations.

J. Jay Lobell, J.D., is President and Chief Operating Officer at Paramount BioSciences. His previous experience includes partnership at Covington & Burling, where he furnished economic, regulatory, business, and litigation suggestions to financial institutions, corporations and individuals.

Russell Ellison, m.d. is Executive Vice President with more than 31 years of senior management experience in pharmaceutical drug development and commercialization he is a previous vice president clinical development at fibrogen, inc. and chief medical officer of sanofi-synthelabo, usa. Dr. Ellison also served as the U.S. vice president of medical affairs and is a former U.S. vice president, medical affairs and chief medical officer of Hoffman la roche.

Benefits of Paramount BioSciences Style

Exactly what makes Paramount BioSciences a preferred acquirer of drugs and developer of biotechnologies is that Lindsay Rosenwald’s development team along a world-wide business development group that assesses and allows for unit and market opportunities. The offices of Paramount BioSciences can be found throughout the world, which includes New York City, London, Boston, Shanghai, San Diego, North Carolina, Orange County (California)). Promising medication candidates are shifted ahead quickly in the certification process. Representatives of all areas in drug creation cycle come together to make sure an understanding to move ahead. The next thing is the creation of product development ideas for the compound and getting supervision personnel. During this period, the chemical substances are usually transferred to Portfolio Businesses with no transition hold-up. The product candidates are backed throughout the specialized medical and regulatory system.

Paramount BioSciences has proved to rapidly perform deals and initiate creation work. Its access to money is a valuable part of any product creation. It supplies Portfolio businesses with the structure that promotes drug candidate’s progression through to market, removing chances of program getting stalled.

Medical and commercial knowledge at the company level helps Paramount Portfolio firms take full advantage of value to in-licensed items.

Background regarding Financial Wherewithal

Paramount BioSciences underneath the authority of Lindsay Rosenwald has produced over $1 billion from outside shareholders in addition to their own investment in Paramount’s portfolio businesses. All firms and clinical studies funded through the company receive substantial financing on all levels of the development circuit.

Linsay Rosenwald has frequent and close interaction with the leading US sell-side and buy-side organizations that include notable medical care individuals, with whom Paramount’s hedge funds invest in the offers not directly involving the organization by itself. Paramount’s employees have real-time understanding of health care capital markets, which led to over $400 million funds for Portfolio Corporations in 2009 year alone, including $200 million by Paramount. This includes $47 million for Cougar Biosciences in partnership with SG Cowen, $37 million for Ziopharm Oncology, $22 MM for Chelsea Therapeutics and $16 million for Innovive Pharmaceuticals. Most of the leading health care funds invested in Paramount this year, which remains a good indication for the introduction of biotechnology and life sciences sectors.

Lindsay Rosenwald & The Sh’or Yoshuv Institute

April 13, 2010 at 5:09 pm

The Sh’or Yoshuv Institute is a very prominent Rabbinical College and has become a standard bearer in Judaic education for four decades.  The Institute provides for educational and spiritual needs for the regions of Far Rockaway and Five Towns, two Jewish communities which make up one of the largest Orthodox Jewish communities in North America when combined.   This congregation consists of over a thousand families who, thanks to the Institute, are able to receive premier educational and spiritual resources.  In addition to these resources, the Institute has a number of Jewish outreach programs with a unique sensitivity to the needs and desires of the Jewish community around the world, as well as individuals who seek to join that community.  The Sh’or Yoshuv Institute uses sensitivity in addition to dedication as it advances the time honored cause of providing a Jewish education.  These wonderful traits are seen mirrored in Dr. Lindsay Rosenwald and his wife, dear friends of the institute itself and outstanding citizens in our community.  They are committed to charity – true philanthropists, selfless and intelligent and good – who are committed to doing good in this world through their sterling discretion and integrity.

Among the exemplary traits of Lindsay Rosenwald and his wife is that they have set a true example for their children, not merely joining in these causes in the vicinity of their children, but actually working directly with their children in supporting many charitable causes.  These events have helped teach their children, but they have also support children’s causes through fund raisers held in their home.  Their children have learned first hand how to do good, and do it wisely.  For Lindsay Rosenwald and his family, the future of all people is a real and ever present concern.  They have repeatedly and eagerly invested in programs to help society, investing especially generously in the area of education.  Benefactors of this nature who, in addition to donations in their region have found themselves able to help specific individuals requiring financial aid, are truly hard to come by.

There is no shortage of stories about Lindsay Rosenwald’s good heart or noble actions.  One of his friends, an artist, became the beneficiary of Dr. Rosenwald’s amazing generosity.  His generosity   has been felt through the purchase of his friend’s paintings which are now proudly displayed in the Institutes lobby.  Not only generous, but humble too, Lindsay agreed to being honored at a Sh’or Yoshuv Annual Banquet with the words “I don’t like the limelight, but you know I will do what it takes to help you out.”

He was true to his word in every case.  Perhaps the most moving story to me involves a time when the Institute faced a major budget crisis.  Major deficits needed to be resolved and so a meeting was held to attend to these issues.  The meeting was held in Dr. Lindsay Rosenwald’s home.  For the vast majority of the meeting, Dr. Rosenwald was completely silent.  After long hours of listening, however, he approached the Rabi and whispered to him that he would gladly cover the entire deficit.  He did not do this publicly and did not seek to be rewarded or applauded for his offer.

Perhaps the great virtues that Lindsay Rosenwald is instilling in his children were also instilled in him by his father.  We are glad to have a building dedicated to his father, David Rosenwald, on our campus.  The Rosenwalds have been amazing friends to the Sh’or Yoshuv Institute for generations.  Their participation in High Holy Days activities and religious services has enriched those spiritual events.  Their commitment to their heritage and their community has helped to sustain a vibrant center of life within and for the Institute.  Their continued aid has helped to inspire the entire administration and has brought great hope for, and resources to create the reality of, a bright and successful future for the Institute.


Search engine optimization by SEO Design Solutions